Примери за използване на Have been administered на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
No launch codes have been administered.
In post-marketing spontaneous reports, there have been cases of medication error where the entire contents(up to 800 µg)of the teriparatide pen have been administered as a single dose.
Single doses up to 20 mg/kg have been administered without apparent toxic effect.
In addition, signs and symptoms of beta blockade(e.g. bradycardia, hypotension, respiratory distress and hypoglycaemia)have been observed in the neonate when beta blockers have been administered until delivery.
In Phase 3 studies, patients have been administered single doses of up to 1,500 mg.
In addition, signs and symptoms of beta-blockade(e.g. bradycardia, hypotension, respiratory distress and hypoglycaemia)have been observed in the neonate when beta-blockers have been administered until delivery.
However, clopidogrel and ASA have been administered together for up to one year see.
Overdose experience based on post-marketing spontaneous reports In post-marketing spontaneous reports, there have been cases of medication error where the entire contents(up to 800 mcg)of the teriparatide pen have been administered as a single dose.
Single doses of 120 mg/ kg bw have been administered to 137 subjects treated with Respreeza.
Overdose experience based on post-marketing spontaneous reports In post-marketing spontaneous reports, there have been cases of medication error where the entire contents(up to 800 micrograms)of a teriparatide pen have been administered as a single dose.
Doses up to 4 mg/kg/week subcutaneously for 10 weeks have been administered without any toxic effect.
Doses up to 2,000 mg have been administered intravenously in clinical trials without dose-limiting toxicity.
As of June 2015, 183 million doses of Gardasil have been administered worldwide.
Doses up to 2250 mg/day have been administered in clinical studies showing a safety profile consistent with that reported in section 4.8.
Doses up to 4 mg/ kg/ week subcutaneously for 10 weeks have been administered without any toxic effect.
Single doses of 300 mcg/kg have been administered subcutaneously to a limited number of healthy volunteers and patients with non-small cell lung cancer without serious adverse reactions.
A single dose of naldemedine(0.01 mg to 3 mg) andmultiple doses of 0.4 mg/day have been administered to patients with OIC in clinical studies.
A large number of Rapinyl doses have been administered during these Phase III studies and high doses of Rapinyl have been used for long periods of administration without any cause for concern over the nature and frequency of reported SAEs.
Repeated daily doses up to 8 mg/kg(maximum total dose 896 mg)in adult patients have been administered in clinical trials with no reported dose-limiting toxicity.
The following transplant medications have been administered in clinical trials with Zenapax without any interactions: cyclosporine, mycophenolate mofetil, gancyclovir, acyclovir, tacrolimus, azathioprine, antithymocyte immune globulin, muromonab-CD3(OKT3), and corticosteroids.
All details concerning veterinary medicinal products(other than the product under study) which have been administered either prior to or concurrently with the test product or during the observation period;
Various formulations of fosaprepitant have been administered to a total of 729 individuals including 347 healthy subjects and 149 patients with CINV.
Single doses up to 1200 mg andmultiple doses up to 1200 mg twice daily have been administered to healthy subjects for nine days without clinically significant adverse events.
Weekly doses of up to 540 and 630 micrograms have been administered in renal cell carcinoma and chronic myelogenous leukaemia clinical trials, respectively.
This also includes patients who have been administered the drug in the long-term(a decade or longer).
Single intravenous doses up to 4,000 mg have been administered to patients without evidence of dose- limiting toxicities.
Doses titrated up to 300 mg once daily have been administered to patients receiving dialysis without adverse outcome.
Single intravenous doses up to 4,000 mg have been administered to patients without evidence of dose-limiting toxicities.
In a compassionate use programme, Mozobil and G-CSF have been administered to patients with acute myelogenous leukaemia and plasma cell leukaemia.
Weekly doses of up to 540 and 630 micrograms have been administered in renal cell carcinoma and chronic myelogenous leukaemia clinical trials, respectively.